Surgepays Net Worth
Surgepays Net Worth Breakdown | SURG |
Surgepays Net Worth Analysis
Surgepays' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Surgepays' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Surgepays' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Surgepays' net worth analysis. One common approach is to calculate Surgepays' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Surgepays' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Surgepays' net worth. This approach calculates the present value of Surgepays' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Surgepays' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Surgepays' net worth. This involves comparing Surgepays' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Surgepays' net worth relative to its peers.
Enterprise Value |
|
To determine if Surgepays is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Surgepays' net worth research are outlined below:
| Surgepays had very high historical volatility over the last 90 days | |
| Surgepays may become a speculative penny stock | |
| About 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from bizjournals.com: Memphis-area company announces multiyear deal with ATT |
Surgepays uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Surgepays. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgepays' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Surgepays' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Surgepays is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgepays backward and forwards among themselves. Surgepays' institutional investor refers to the entity that pools money to purchase Surgepays' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-06-30 | 26.2 K | Corsair Capital Management Llc | 2024-06-30 | 19.9 K | Royce & Associates, Lp | 2024-09-30 | 18.6 K | Simplex Trading, Llc | 2024-06-30 | 17.5 K | Advisor Group Holdings, Inc. | 2024-06-30 | 16.6 K | Ubs Group Ag | 2024-06-30 | 14.1 K | James Investment Research, Inc. | 2024-09-30 | 13 K | Goss Wealth Management Llc | 2024-06-30 | 13 K | Cetera Investment Advisers | 2024-06-30 | 12.2 K | Vanguard Group Inc | 2024-09-30 | 587 K | Cable Car Capital Llc | 2024-09-30 | 515 K |
Follow Surgepays' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.28 M.Market Cap |
|
Project Surgepays' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.55 | 0.58 | |
| Return On Capital Employed | 0.65 | 0.68 | |
| Return On Assets | 0.49 | 0.52 | |
| Return On Equity | 0.73 | 0.69 |
When accessing Surgepays' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Surgepays' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Surgepays' profitability and make more informed investment decisions.
Evaluate Surgepays' management efficiency
Surgepays has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 3 M, while Intangible Assets are projected to decrease to roughly 2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.99 | 3.96 | |
| Tangible Book Value Per Share | 1.69 | 3.06 | |
| Enterprise Value Over EBITDA | 4.12 | 4.33 | |
| Price Book Value Ratio | 3.26 | 3.42 | |
| Enterprise Value Multiple | 4.12 | 4.33 | |
| Price Fair Value | 3.26 | 3.42 | |
| Enterprise Value | 82.8 M | 86.9 M |
The strategic initiatives led by Surgepays' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 0.192 | Revenue 113 M | Quarterly Revenue Growth (0.58) | Revenue Per Share 6.864 | Return On Equity (0.05) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgepays time-series forecasting models is one of many Surgepays' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Surgepays Earnings per Share Projection vs Actual
Surgepays Corporate Management
| Carter Matzinger | Chief LogicsIQ | Profile | |
| CPA CIA | CFO COO | Profile | |
| John Mott | Chief Officer | Profile | |
| Brian CFA | Managing MZ | Profile | |
| MBA JD | Secretary Services | Profile | |
| Jeremy Gies | I Fintech | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.